[X]
|
QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013
|
|
|
OR
|
|
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Large Accelerated Filer
|
[ ]
|
Accelerated Filer
|
[ ]
|
|
Non-accelerated Filer
|
[ ]
|
Smaller Reporting Company
|
[X]
|
|
(Do not check if smaller reporting company)
|
|
Page
|
|
|
||
FINANCIAL STATEMENTS.
|
3
|
|
|
||
3
|
||
4
|
||
5
|
||
6
|
||
|
||
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
12
|
|
|
||
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
|
14
|
|
|
||
CONTROLS AND PROCEDURES.
|
14
|
|
|
||
|
||
|
||
RISK FACTORS.
|
14
|
|
|
||
EXHIBITS.
|
15
|
|
16
|
||
17
|
September 30,
2013
(unaudited)
$
|
December 31,
2012
$
|
|
ASSETS
|
||
|
||
Current Assets
|
||
Cash
|
10,338
|
12,650
|
Prepaid expenses
|
104
|
–
|
|
||
Total Current Assets
|
10,442
|
12,650
|
|
||
Other Assets
|
||
Deferred financing costs
|
5,703
|
–
|
|
||
Total Assets
|
16,145
|
12,650
|
|
||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
|
||
|
||
Current Liabilities
|
||
Accounts payable and accrued liabilities
|
381,196
|
119,732
|
Accounts payable and accrued liabilities – related parties
|
124,433
|
57,219
|
Due to related parties
|
300,000
|
300,000
|
|
||
Total Current Liabilities
|
805,629
|
476,951
|
|
||
Non-Current Liabilities
|
||
Convertible debentures, net of unamortized discount of $56,015
|
3,985
|
–
|
|
||
Total Liabilities
|
809,614
|
476,951
|
|
||
Stockholders’ Equity (Deficit)
|
||
Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: nil preferred shares
|
–
|
–
|
Class A Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: 7,500,000 shares
|
7,500
|
7,500
|
Common Stock
Authorized: 2,000,000,000 common shares, with a par value of $0.001 per share
Issued and outstanding: 377,203,075 and 376,603,075 shares, respectively
|
377,203
|
376,603
|
Additional paid-in capital
|
349,275
|
283,875
|
Deficit accumulated during the development stage
|
(1,527,447)
|
(1,132,279)
|
|
||
Total Stockholders’ Equity (Deficit)
|
(793,469)
|
(464,301)
|
|
||
Total Liabilities and Stockholders’ Equity (Deficit)
|
16,145
|
12,650
|
For the Three
Months Ended
September 30,
2013
$
|
For the Three
Months Ended
September 30,
2012
$
|
For the Nine
Months Ended
September 30,
2013
$
|
For the Nine
Months Ended
September 30,
2012
$
|
Accumulated from
November 3, 2008
(date of inception)
to September 30,
2013
$
|
|
|
|||||
Revenue
|
–
|
–
|
–
|
–
|
–
|
|
|||||
Operating Expenses
|
|||||
|
|||||
Consulting fees
|
206,000
|
105,000
|
317,750
|
309,000
|
910,000
|
General and administrative
|
963
|
18,773
|
3,624
|
56,376
|
101,359
|
Management fees
|
–
|
–
|
–
|
–
|
43,727
|
Professional fees
|
33,466
|
19,834
|
42,966
|
40,623
|
218,426
|
Transfer agent fees
|
91
|
569
|
260
|
670
|
18,868
|
|
|||||
Total Operating Expenses
|
240,520
|
144,176
|
364,600
|
406,669
|
1,292,380
|
|
|||||
Loss Before Other Expenses (Income)
|
(240,520)
|
(144,176)
|
(364,600)
|
(406,669)
|
(1,292,380)
|
|
|||||
Other Expenses (Income)
|
|||||
|
|||||
Accretion expense
|
–
|
2,805
|
–
|
8,306
|
16,800
|
Impairment of intangible assets
|
–
|
–
|
–
|
–
|
92,538
|
Interest expense
|
23,171
|
12,246
|
30,568
|
34,654
|
106,811
|
Loss (gain) on settlement of debt
|
–
|
–
|
–
|
–
|
18,918
|
|
|||||
Total Other Expenses (Income)
|
23,171
|
15,051
|
30,568
|
42,960
|
235,067
|
|
|||||
Net Loss for the Period
|
(263,691)
|
(159,227)
|
(395,168)
|
(449,629)
|
(1,527,447)
|
|
|||||
Net Loss Per Share, Basic and Diluted
|
–
|
–
|
–
|
–
|
|
|
|||||
Weighted Average Shares Outstanding
|
377,203,075
|
347,380,000
|
377,035,865
|
347,380,000
|
For the Nine
Months Ended
September 30,
2013
$
|
For the Nine
Months Ended
September 30,
2012
$
|
Accumulated from
November 3, 2008
(date of inception)
to September 30,
2013
$
|
|
|
|||
Operating Activities
|
|||
Net loss
|
(395,168)
|
(449,629)
|
(1,527,447)
|
Adjustment to reconcile net loss to cash used in operating activities:
|
|||
Accretion of debt discount
|
3,985
|
8,306
|
20,785
|
Amortization of deferred financing costs
|
1,297
|
–
|
1,297
|
Loss (gain) on settlement of debt
|
–
|
–
|
18,918
|
Impairment of intangible assets
|
–
|
–
|
92,538
|
Shares issued for management fees
|
6,000
|
–
|
13,000
|
Stock-based compensation
|
–
|
–
|
2,227
|
Changes in operating assets and liabilities:
|
|||
Prepaid expense and deposits
|
(104)
|
7,575
|
(104)
|
Accounts payable and accrued liabilities
|
261,464
|
42,499
|
428,803
|
Accounts payable and accrued liabilities – related
|
67,214
|
26,270
|
124,433
|
Due to related parties
|
–
|
–
|
11,965
|
|
|||
Net Cash Used in Operating Activities
|
(55,312)
|
(364,979)
|
(813,585)
|
|
|||
Investing activities
|
|||
Acquisition of intangible assets
|
–
|
–
|
(10,000)
|
|
|||
Net Cash Used by Investing Activities
|
–
|
–
|
(10,000)
|
|
|||
Financing activities
|
|||
Proceeds from convertible debenture
|
53,000
|
–
|
53,000
|
Proceeds from loan payable
|
–
|
60,000
|
709,600
|
Repayments of loan payable
|
–
|
–
|
(149,449)
|
Proceeds from related parties
|
–
|
–
|
2,649
|
Repayments to related parties
|
–
|
–
|
(25,000)
|
Capital contribution
|
–
|
–
|
200,600
|
Proceeds from the issuance of common stock
|
–
|
–
|
42,523
|
|
|||
Net Cash Provided by Financing Activities
|
53,000
|
60,000
|
833,923
|
|
|||
Change in Cash
|
(2,312)
|
(304,979)
|
10,338
|
|
|||
Cash, Beginning of Period
|
12,650
|
320,178
|
–
|
|
|||
Cash, End of Period
|
10,338
|
15,199
|
10,338
|
|
|||
Supplemental Disclosures
|
|||
Interest paid
|
–
|
–
|
–
|
Income tax paid
|
–
|
–
|
–
|
|
|||
Non-cash investing and financing activities
|
|||
Debt discount due to beneficial conversion feature
|
60,000
|
–
|
60,000
|
Forgiveness of related party debt
|
–
|
–
|
2,649
|
Issuance of common shares to settle debt
|
–
|
–
|
580,055
|
Issuance of common shares for acquisition of assets
|
–
|
–
|
250,000
|
Issuance of preferred shares for acquisition of assets
|
–
|
–
|
7,500
|
Issuance of note payable for acquisition of assets
|
–
|
–
|
325,000
|
Fair Value Measurements Using
|
|||||
Quoted prices in
active markets for
identical instruments
(Level 1)
$
|
Significant other
observable inputs
(Level 2)
$
|
Significant
unobservable inputs
(Level 3)
$
|
Balance,
September 30,
2013
$
|
Balance,
December 31,
2012
$
|
|
Convertible debenture
|
–
|
–
|
–
|
3,985
|
–
|
·
|
Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and
|
·
|
Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.
|
|
a)
|
On June 7, 2013, the Company entered into a $32,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on December 7, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (December 4, 2013) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company’s common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at September 30, 2013, the Company recorded accrued interest of $819 (December 31, 2012 - $nil), which has been included in accounts payable and accrued liabilities.
|
b)
|
On July 15, 2013, the Company entered into a $27,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on January 11, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (January 11, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company’s common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at September 30, 2013, the Company recorded accrued interest of $464 (December 31, 2012 - $nil), which has been included in accounts payable and accrued liabilities.
|
|
a)
|
As at September 30, 2013, the Company owes $300,000 (December 31, 2012 - $300,000) to a company controlled by officers and directors of the Company. The amount owing is unsecured, bears interest at 10% per annum, and due on demand. As at September 30, 2013, the Company has recorded accrued interest of $64,658 (December 31, 2012 - $42,219) which has been included in accounts payable and accrued liabilities – related parties.
|
|
b)
|
As at September 30, 2013, the Company owes $10,225 (December 31, 2012 - $nil) to companies under common control by officers and directors of the Company which has been included in accounts payable and accrued liabilities – related parties. The amounts owing are unsecured, non-interest bearing, and due on demand.
|
|
c)
|
For the period ended September 30, 2013, the Company incurred $33,750 (December 31, 2012 - $43,500) to the President and CEO of the Company for consulting services. As at September 30, 2013, the Company owes $48,750 (December 31, 2012 - $15,000), which has been included in accounts payable and accrued liabilities – related parties. The amounts owing are unsecured, non-interest bearing, and due on demand.
|
|
d)
|
For the period ended September 30, 2013, the Company incurred $800 (December 31, 2012 - $nil) to the President and CEO of the Company for reimbursement of expenses which has been included in accounts payable and accrued liabilities – related parties.
|
|
a)
|
On October 12, 2011, the Company entered into a verbal consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On July 18, 2012, the Board of Directors reviewed the consulting agreement and authorized an increase to the monthly consulting fee from $3,000 to $3,750 per month beginning July 2012. On October 1, 2012, the Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,750 to $3,000 per month beginning October 2012.
|
|
b)
|
On October 12, 2011, the Company entered into a consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $27,500. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated.
|
|
c)
|
On October 12, 2011, the Company entered into a consulting agreement with the President and CEO of the Company whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On June 10, 2012, the Board of Directors authorized an increase to the monthly consulting fee from $3,000 to $6,000 per month beginning June 2012. On July 18, 2012, the Board of Directors reviewed the consulting agreement and adjusted the monthly consulting fee to $3,750 beginning July 2012.
|
|
d)
|
On January 2, 2013, the Company entered into a consulting agreement with The Holden Group, LLC (“Holden”) whereby the Company paid Holden $2,000 and issued 600,000 restricted common shares of the Company upon the execution of the agreement as well as pay $500 on each of the first, second and third month anniversaries of the agreement. These final three payments have been accrued and recorded in accounts payable and accrued liabilities.
|
|
September 30,
2013
$
|
December 31,
2012
$
|
Current Assets
|
10,442
|
12,650
|
Current Liabilities
|
805,629
|
476,951
|
Working Capital Deficit
|
(795,187)
|
(464,301)
|
|
September 30,
2013
$
|
September 30,
2012
$
|
Cash Flows used in Operating Activities
|
(55,312)
|
(364,979)
|
Cash Flows from Financing Activities
|
53,000
|
60,000
|
Net Decrease in Cash During Period
|
(2,312)
|
(304,979)
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
101.INS
|
XBRL Instance Document.
|
X
|
|||
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
HDS INTERNATIONAL CORP.
|
||
(the “Registrant”)
|
||
|
||
BY:
|
TASSOS RECACHINAS
|
|
Tassos Recachinas
|
||
President
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
101.INS
|
XBRL Instance Document.
|
X
|
|||
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
1.
|
I have reviewed this Form 10-Q for the period ended September 30, 2013 of HDS International Corp.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and,
|
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
November 6, 2013
|
TASSOS RECACHINAS
|
Tassos Recachinas
|
||
Principal Executive Officer and Principal Financial Officer
|
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
TASSOS RECACHINAS
|
|
Tassos Recachinas
|
|
Chief Executive Officer and Chief Financial Officer
|
4. Related Party Transactions (Details) (USD $)
|
Sep. 30, 2013
|
Sep. 29, 2013
|
Jun. 30, 2013
|
Dec. 31, 2012
|
---|---|---|---|---|
Related Party Transactions [Abstract] | ||||
Related Party Transaction, Due from (to) Related Party | $ 300,000 | $ 300,000 | ||
Debt Instrument, Interest Rate, Effective Percentage | 10.00% | |||
Interest Payable | 64,658 | 42,219 | ||
Due to Related Parties | 10,225 | |||
Due to Officers or Stockholders, Current | 33,750 | 43,500 | ||
Accounts Payable and Accrued Liabilities - Other Related Party | 48,750 | 15,000 | ||
$ 124,433 | $ 800 | $ 57,219 |
6M%Z8J;RLA87 W2M0ZX/O8SZ*ZTW16WV0`E1+V#&:R29HB1.TS[?J3)!Y&F9/`8J>;WC:WXX
M-%9>O8F3,`J_VJY7KZ=TST21C7(SR'0YO;ZS&>P\D,7'>N-\"AVBG;\3^R
M>E<<&^O`M_`H-/.A:-3R6$Y^::M3=RCU4K5PG-;]NX?C4P['06@&\+:JVLL7
M\8#K@>SJ?P```/__`P!02P,$%``&``@````A`'HRQ#E0`P``BPL``!D```!X
M;"]W;W)K :
M;\Q"B&9EVSPM<(6X11M 0"9UM6U;G%H!QU<%-!^<:10"+>YJ$L5M>W"%&YK^_
M.^"6XS5L#ZO`1'!8P9^+D_A5HA-B71T`1?%6S=^L$T3#.LMC76U73DY[S?
MC()Y?1CI<^:K["B7U/SGMJ,5OG(`BV,P9XBSY."3V]'65/O_;4>Y=`TC)/3:
MU*'U=G3_T?X:A?K_W8YZC?NO9D=WN"E^G?N,#-X7L*.WK:9C1\%G;WV6\T10
M,3F++L)IX_+53ZY!WFM>>EZEC]9>EK3?@-FKQVLO=[U?"IY!K5QX>?^;!/TX
MR']KN7(!3'=H$0>]F-,:@3L]5W&/1AR[@P&,XK+#NORKB2!#'.E3RESV)XAX
M&^#>`;X2CH,R*L2M.CAH>\2IP>G(1KW;;H7BUENQ1_N#1P=/5ABR_=W![L[7
M7%AIU_+]59`0C/?/+&4,K*]^CJ,CGG?;E&/ASO9@=_=@Q<*%9(5>'.^4#G29
M$_Y6U.%9>6<^?C8"F)=3`G'0KNHWA,T5V%P12<(4$N"FO*1%L;AAW$=.R#
M%Y?IH:BCK.`J&!?4!?2OS@H0Y-[>X/'!]@IZ[^\)7QG)!<-/B!VM?<>0\M&+
M-RV]L)0_3`CWYZM%57V%=PUPG`3L/UFS(G`AOV;R:<*97MG]?*P;?6K6/2&%
MT&_I@I[ Z]+>X`+-KRCK
M?P```/__`P!02P,$%``&``@````A`!/BTM8R`0``0`(``!$`"`%D;V-0'-#\:7&%1WJ)1[';Y)K.*S>LA.]9WU]&53'$XD\93O\_IG(VKT#IN%_WPLRO1I3_W^8=ZEFU:[>=.1/^2;LJB*
M7=TGN0$/M-OG^\']@)0>'[8Y]8`->Z_,=DOCJ[E(S'MC\/C0#-"_>?967;WN
M52_%FUOFVR@_9C3:-$]L!IZ*XAM#_2TKHLJ#3FVGF8$_R]XVVZ6O^_JOXLW+
M\N>7FJ9[0CUB'5ML?UI9M:$1)9G^:,*4-L6>`J"_O4/.K$$CDOYH_K_EV_IE
M:8RG_
2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WYGC"VENPL
M_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F\=%]0.
M?#:8,25-,,&G*H&AAQZ8/(#DMQS-TJV_````__\#`%!+`P04``8`"````"$`
M6$GB=
P),^-[(2FFZ3S'[(%KY(:$T>C)=B<"%P"2A6*8&((@L:A
M?4YQ%0_8CL[JA=LR#(ADTTM!*#]1M4QH,3/3IM41F&;7EE+2')
7B``3@MU46LC1`D>RC^WLJ-NU^
M:7O!S`]=CP#<6O.F?2FD2]O*WYI6E/\J$-&NE!.JG7C`7MOIC$8^\8.OO3B*
M41?@<]9FJT4M3A94#>S9'#-9@V0.GJ]'!*%(['<)[I8`V0;2\+ZB\<)Y!^5R
M#4FN0#`B'2,\]P)Q@-:%&T0\G9L$@ZZV=>'FD8O;CGZB(&P`\3$BO8=`U&"?
MZ=0D>&F#[YX:Q1LG"A)UFA+7\R)L3Y&=!OX-Q2"VZ;0DV*#EX6T3!6&:%L/6
M]&SMX^KU1&I!D4^G)<$&+6/C1$'\,RUFJ)DB^VVU@D=H2;!17WVTJKX4!%2Y
MY-E`I/<02+'P$6H2;"@6X%0E"J(4DXT'FU-EOLX<\9(3;7*[D&"#5X@W3A1$
M9S(@S!0,V6]G,GZ$E@0;F32.6Z(@U_7H#/P@^AZ7\X\FRO4?C!RR_Z,STJXSGR,B+0-AB
M8W%]M6'`&^#SJJ.V'"403I\,D8FA($0_([5AK#9,>`-\7G7
EI$#A'%VTOPA:WY$4"'6?/8R
MC"PC!PA'[N6UN)6],U&"&)
R%^PZ56:L"3Z&R'-V%>=L8GJ+Q?.(M
M%G/76XXW`LPF#7@*%??]*FZK`D^A8K\[4[#>=`6>#Q%[/AV1J,7'N"F9,*7I
M=EWCNP'S$$:17%,VJVT?=$6M\)'MJN>MXH&J82([IK(QH3W4!8&*?]XZCK>V
MGJ%*LY83#'%6*F5/YZ-IO-P'$&X=TN%O&%(Z7O944A>_M-!
M44NE2<8M"5Q;DOC-').6`ZYO%A+H12F/4B+)>MGPDP>)![)%33"-HP2(C3EZ
M*9U=3[D%-B')-;*L_+GO@1$"MOA^'2WFR^`>MB5K8S;]F-G$#=F:$-P$Y$TM
M(`#!G>KX750C"ZHVTVT,<%Y&?*'01)@AJ04X"F&CW\%79(%\
Consolidated Statements of Operations (Unaudited) (USD $)
|
3 Months Ended | 9 Months Ended | 59 Months Ended | ||
---|---|---|---|---|---|
Sep. 30, 2013
|
Sep. 30, 2012
|
Sep. 30, 2013
|
Sep. 30, 2012
|
Sep. 30, 2013
|
|
Operating Expenses | |||||
Consulting fees | $ 206,000 | $ 105,000 | $ 317,750 | $ 309,000 | $ 910,000 |
General and administrative | 963 | 18,773 | 3,624 | 56,376 | 101,359 |
Management fees | 43,727 | ||||
Professional fees | 33,466 | 19,834 | 42,966 | 40,623 | 218,426 |
Transfer agent fees | 91 | 569 | 260 | 670 | 18,868 |
Total Operating Expenses | 240,520 | 144,176 | 364,600 | 406,669 | 1,292,380 |
Loss Before Other Expenses (Income) | (240,520) | (144,176) | (364,600) | (406,669) | (1,292,380) |
Other Expenses (Income) | |||||
Accretion expense | 2,805 | 8,306 | 16,800 | ||
Impairment of intangible assets | 92,538 | ||||
Interest expense | 23,171 | 12,246 | 30,568 | 34,654 | 106,811 |
Loss (gain) on settlement of debt | 18,918 | ||||
Total Other Expenses (Income) | 23,171 | 15,051 | 30,568 | 42,960 | 235,067 |
Net Loss for the Period | $ (263,691) | $ (159,227) | $ (395,168) | $ (449,629) | $ (1,527,447) |
Weighted Average Shares Outstanding (in Shares) | 377,203,075 | 347,380,000 | 377,035,865 | 347,380,000 |
5. Common Stock
|
3 Months Ended |
---|---|
Sep. 30, 2013
|
|
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity Note Disclosure [Text Block] |
5. Common Stock
On January 2, 2013, the Company issued 600,000 common shares with a fair value of $6,000 for consulting services. The fair value of the common shares was determined by using the closing trading price on the measurement date.
|
5. Common Stock (Details) (USD $)
|
3 Months Ended | |
---|---|---|
Mar. 31, 2013
|
Mar. 31, 2013
|
|
Stockholders' Equity Note [Abstract] | ||
Stock Issued During Period, Shares, Issued for Services (in Shares) | 600,000 | 600,000 |
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 6,000 |
1. Nature of Operations and Continuance of Business
|
3 Months Ended |
---|---|
Sep. 30, 2013
|
|
Natureof Operationand Continuanceof Business [Abstract] | |
Natureof Operationand Continuanceof Business |
1. Nature of Operations and Continuance of Business
HDS International Corp. (the “Company”) was incorporated on November 3, 2008 under the laws of the State of Nevada. A substantial portion of the Company’s activities has involved developing a business plan and establishing contacts and visibility in the marketplace and the Company has not generated any revenue to date. The Company plans to engage in the business of providing renewable energy and eco-sustainability solutions based on its licensed technologies.
On June 11, 2012, HDS Energy and Ecosystems NB, Ltd., the Company’s wholly owned subsidiary, was incorporated in the Province of New Brunswick, Canada to manage the operations and other business development efforts.
Going Concern
These consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has generated no revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future. As of September 30, 2013, the Company had a working capital deficiency of $795,187 and an accumulated deficit of $1,527,447. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's future business. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These consolidated
financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
|
3. Convertible Debenture
|
3 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Sep. 30, 2013
|
|||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||
Derivative Instruments and Hedging Activities Disclosure [Text Block] |
3. Convertible Debentures
In accordance with ASC 470-20, “Debt with Conversion and Other Options”, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $32,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the nine months ended September 30, 2013, the Company had amortized $2,376 (December 31, 2012 - $nil) of the debt discount to interest expense. As at September 30, 2013, the carrying value of the debenture was $2,376 (December 31, 2012 - $nil).
In accordance with ASC 470-20, “Debt with Conversion and Other Options”, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $27,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the nine months ended September 30, 2013, the Company had amortized $1,609 (December 31, 2012 - $nil) of the debt discount to interest expense. As at September 30, 2013, the carrying value of the debenture was $1,609 (December 31, 2012 - $nil).
|
6. Commitments
|
3 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2013
|
|||||||||||||
Disclosure Text Block Supplement [Abstract] | |||||||||||||
Commitments Disclosure [Text Block] |
6. Commitments
During the period ended September 30, 2013, the Company incurred $27,000 (December 31, 2012 - $38,250) in consulting fees relating to this agreement, of which $33,000 (December 31, 2012 - $6,000) is recorded in the account payable balance as at September 30, 2013.
During the period ended September 30, 2013, the Company incurred $247,500 (December 31, 2012 - $330,000) in consulting fees relating to this agreement, of which $316,000 (December 31, 2012 - $91,000) is recorded in the account payable balance as at September 30, 2013.
During the year ended September 30, 2013, the Company incurred $33,750 (December 31, 2012 - $43,500) in consulting fees relating to this agreement, of which $48,750 (December 31, 2012 - $15,000) is recorded in the account payable – related parties balance as at September 30, 2013.
|
4. Related Party Transactions
|
3 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2013
|
|||||||||||||
Related Party Transactions [Abstract] | |||||||||||||
Related Party Transactions Disclosure [Text Block] |
4. Related Party Transactions
|